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I. INTRODUCTION
Since their introduction in the mid-twentieth century, antibiotics have
become a mainstay of poultry production for purposes ranging from growth
promotion to disease treatment and control. Nevertheless, for almost as
long, there have been concerns about the role that these agricultural uses
play in the development of antibiotic resistant bacteria. The issue of
antibiotic resistance in general is fast becoming a public health crisis and
scrutiny of agriculture as a contributing cause continues. Nevertheless, to
date, neither regulatory efforts to curb agricultural usage nor private sector
actions in response to consumer demand and public-interest campaigns
have led to significant changes in addressing the problem.
This article will argue that the most effective course for dealing with
the role of agriculture in this public health issue is to enact regulations that
* Dorinda L. Peacock is a partner in the corporate and securities practice group of
Womble Carlyle Sandridge & Rice LLP, focusing on mergers and acquisitions and
other complex commercial transactions. In addition, she has served in an outside
general counsel role for various clients in the food industry, advising them on all
aspects of their business. The views expressed in this article are those of the author and
are not made on behalf of any current or former client of the author. Special thanks to
Neal D. Fortin, Director of the Institute for Food Laws & Regulations at the Michigan
State University College of Agriculture and Natural Resources, for his review and
feedback on this article.
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allow the Food Safety Inspection Service (FSIS)1 to promulgate more
robust labeling requirements for companies making claims about
antibiotics use on their poultry products. These requirements should
empower consumers with the information they need to encourage change in
the industry and align consumer choices with principles for the judicious
use of antibiotics backed by the U.S. Food and Drug Administration
(FDA),2 without prematurely forcing producers to abandon tools valuable
in protecting food safety and animal welfare.
Part I will set forth the issue presented by antibiotic resistant bacteria
and the role the poultry industry plays in its development. In Parts II and
III, respectively, this article will describe the regulatory and marketplace
responses to antibiotic resistance, including the labeling of poultry products
produced without antibiotics. Part IV will take a closer look at the use of
antibiotics in the poultry industry, and Part V will consider the problem
presented by confusing, inaccurate, or misleading labeling by looking
specifically at an advertising and labeling campaign launched by poultry
giant Tyson Foods, Inc. (Tyson) in 2007. Finally, in Part VI, this article
will suggest that the adoption of improved labeling policies would not only
prevent future problems such as those presented by Tyson's campaign, but
would strengthen the market for poultry raised either without antibiotics or
through the judicious use of antibiotics by empowering consumers with
clear and consistent information.
II. THE PROBLEM OF ANTIBIOTIC RESISTANCE
Antibiotics are powerful medical tools for treating bacterial infections
in both humans and animals.3  Their availability has made previously
1. FSIS is an agency within the U.S. Department of Agriculture with responsibility
for, among other things, making sure that poultry products are safe, safely packaged,
and labeled in compliance with the Poultry Products Inspection Act. U.S. DEP'T OF
AGRIC., ABOUT FSIS, http://www.fsis.usda.gov/AboutFSIS/index.asp (last visited Jan.
6,2014).
2. The FDA is an agency within the U.S. Department of Health and Human
Services. As part of its broad jurisdiction over the safety of food and drugs pursuant to
the Food, Drug and Cosmetic Act, it has responsibility over approval of new animal
drugs, including those used in food-producing animals. See generally U.S. FOOD &
DRUG ADMIN., FDA ORGANIZATION, http://www.fda.gov/AboutFDA/CentersOffices
/default.htm (last visited Jan. 6, 2014).
3. See generally Ctr. for Veterinary Med.., U.S. Dep't of Health & Human Servs.,
Guidance for Industry: The Judicious Use of Medically Important Antimicrobial Drugs
in Food-Producing Animals, 209 GUIDANCE FOR INDUSTRY 1 (2012), available at
http://www.fda.gov/downloads/animalveterinary/guidancecomplianceenforcement
/guidanceforindustry/ucm216936.pdf [hereinafter Guidance for Industry # 209]; Ian
Phillips et al., Does the Use of Antibiotics in Food Animals Pose a Risk to Human
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deadly conditions highly treatable, but the use of an antibiotic naturally
results in bacteria gradually becoming resistant to it.4 When this occurs, a
drug that once was capable of curing an infection will no longer be
effective against it.' There is wide agreement that the misuse or overuse of
antibiotics leading to more rapid development of resistant bacteria is a
6major public health concern. However, the issue is complex and there is
little agreement over how best to address it, as antibiotics are used
extensively in both human and animal medicine.7 Nevertheless, because
agriculture is a major consumer of antibiotic drugs, food producers have
come under scrutiny.
Specifically, there is evidence that animals treated with antibiotics
become carriers of strains of bacteria that are resistant to antibiotics of that
type or class.9 When humans consume products from those animals, they
are exposed to those drug-resistant bacteria.' 0 If a person exposed to drug-
Health? A Critical Review of Published Data, 53 J. ANTIMICROBIAL CHEMOTHERAPY
28 (2003), available at http://www.vet.k-state.edu/depts/dmp /pdf/ANTIBIOTICS.pdf,
see also Natural Res. Def. Council v. U.S. Food & Drug Admin., 884 F. Supp.2d 127,
127 (S.D.N.Y. 2012); Natural Res. Def. Council v. U.S. Food & Drug Admin., 872 F.
Supp.2d 318, 318 (S.D.N.Y. 2012). Antibiotics are a kind of antimicrobial agent and
this article, as well as much of the literature on this subject, sometimes uses the terms
interchangeably. The Centers for Disease Control and Prevention define antimicrobial
agents this way: "[a] general term for the drugs, chemicals, or other substances that
either kill or slow the growth of microbes. Among the antimicrobial agents in use
today are antibacterial drugs (which kill bacteria), antiviral agents (which kill viruses),
antifungal agents (which kill fungi), and antiparisitic drugs (which kill parasites)."
CTRS. FOR DISEASE CONTROL, GLOSSARY, http://www.cdc.gov/drugresistance
/glossary.html#antimicrobialagents (last visited Jan. 6, 2014).
4. Phillips et al., supra note 3, at 28; Ctr. for Veterinary Med., U.S. Dep't of Health
& Human Servs., supra note 3, at 4; see also Natural Res. Def Council, F. Supp. 2d at
131; Natural Res. Def Council, F. Supp. 2d at 323.
5. Phillips et al., supra note 3, at 28; Ctr. for Veterinary Med., U.S. Dep't of Health
& Human Servs., supra note 3, at 4; see also Natural Res. Def Council, F. Supp. 2d at
131; Natural Res. Def Council, F. Supp. 2d at 322.
6. See generally Ctr. for Veterinary Med., U.S. Dep't of Health & Human Servs.,
supra note 3, at 5-17; see also Natural Res. Def Council, F. Supp. 2d at 131; Natural
Res. Def Council, F. Supp. 2d at 323.
7. Phillips et al., supra note 3, at 29; see also Natural Res. Def Council, F. Supp.
2d at 131-34; Natural Res. Def Council, F. Supp. 2d at 322.
8. Phillips et al., supra note 3, at 28-29; Ctr. for Veterinary Med., U.S. Dep't of
Health & Human Servs., supra note 4, at 3; Natural Res. Def Council, F. Supp. 2d at
131-132; Natural Res. Def Council, F. Supp. 2d at 322-23.
9. Phillips et al., supra note 3, at 32-33.
10. Phillips et al., supra note 3, at 33 (stating that "[i]t is well known that antibiotic-
resistant bacteria that have been selected in animals may contaminate meat derived
from those animals and that such contamination also declines when the selecting
antibiotics are not used").
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resistant bacteria in this way becomes ill, the infection may not be treatable
by the antibiotic to which those bacteria are resistant or by others in its
class." Evidence also suggests that farm workers exposed to these animals
may become infected with these bacteria, whether or not they become ill.12
The drug-resistant bacteria may spread to the environment as well.13 While
there is not agreement on how to fix the problem, concern continues to
14
grow.
III. MARKETPLACE RESPONSE TO ANTIBIOTIC RESISTANCE
In response to growing consumer awareness of the dangers of
antibiotic resistance, however poorly understood by consumers, food
companies have begun to take steps to curb their use.' 5
11. Ctr. for Veterinary Med., U.S. Dep't of Health & Human Servs., supra note 3, at
4.
12. Phillips et al., supra note 3, at 33 (stating that "[a]nimals that carry, or in certain
cases are infected by, resistant organisms are a hazard to those who work with them
since the organisms can be transferred by direct contact").
13. THE PEW COMMISSION ON INDUSTRIAL FARM PRODUCTION, PUTTING MEAT ON
THE TABLE: INDUSTRIAL FARM ANIMAL PRODUCTION IN AMERICA, 23, 25 (2008),
available at http://www.pewtrusts.org/uploadedFiles/wwwpewtrustsorg/Reports/
IndustrialAgriculture/PCIFAP_FINAL.pdf (noting that antibiotics are present in
animal waste and have been found in surface waters near agricultural facilities)
[hereinafter PEW COMMISSION].
14. There does not appear to be agreement even among scientists as to the extent of
the problem or the best way to address it. For example, some have advocated banning
the use of antibiotics for growth promotion in agriculture, as has been done in a number
of European Union countries, including Denmark and Sweden. Phillips et al., supra
note 3, at 44. However, a coalition of scientists reviewing the evidence regarding use
of antibiotics in agriculture point out a countervailing argument to that approach:
An important finding, for policy purposes, is that risk management strategies that focus
on eliminating resistance are expected to create less than one percent of the public
health benefit of strategies that focus on reducing microbial loads (resistant or not). An
even more disturbing conclusion was that, if the banning of fluoroquinolones gave even
a modest increase in the variance of microbial loads on chickens leaving the processing
plant, it would create far more cases of human infection than cases of resistant infection
that it might prevent. Id. at 42.
15. See Elizabeth Weise, 'Natural' Chickens Take Flight, USA TODAY, Jan. 23,
2006, http://usatoday30.usatoday.com /news/health/2006-01-23-natural-chickens
x.htm. Ms. Weise notes that:
[flour of the nation's top 10 chicken producers have virtually ended
a practice that health and activist groups for years charged was
causing a public health crisis: feeding broiler chickens low doses of
antibiotics to make them grow faster and stay healthy. Tyson Foods,
Gold Kist, Perdue Farms and Foster Farms say they stopped using
226 [VOL. 9
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A recent survey by Consumer Reports indicated that eighty-six
percent of those surveyed thought that meat raised without antibiotics
should be available for purchase in their local market.16 Customer surveys
by Tyson, conducted in preparation for a failed "raised without antibiotics"
marketing campaign it launched in 2007, indicated that ninety-one percent
of consumers thought it was "important to have chicken produced and
labeled 'raised without antibiotics"' and that they were willing to pay more
for such a product.17
Representative Louise Slaughter, a member of the House of
Representatives for the Twenty-Eighth District of New York and a
microbiologist, has made antibiotic resistance one of her signature issues.'8
In February 2012, she surveyed over sixty food companies and producers
to determine their stance on the issue.' 9  Thirty-one companies and
producers responded to the request for information and Representative
Slaughter gathered information from publicly available sources on the
policies of an additional twenty-two companies and producers.20
Responses indicated that many national brands have moved away from the
routine use of antibiotics for growth promotion, though they are still used
regularly by most companies for prevention and control of disease.2 ' The
antibiotics for growth promotion. In addition to ending a practice
that Europe banned and McDonald's ended a month ago, the four
companies also have severely limited antibiotic use for routine
disease prevention, though antibiotics are still used to treat disease
outbreaks.
16. CONSUMER REPORTS, MEAT ON DRUGS: THE OVERUSE OF ANTIBIOTICS IN FOOD
ANIMALS & WHAT SUPERMARKETS AND CONSUMERS CAN DO TO STOP IT 3 (2012),
http://www.consumerreports.org/content/dam/cro/news-articles/health/CR%20
Meat%200n%2ODrugs%20Report%2007-12b.pdf.
17. Tyson Chickens 'Raised Without Antibiotics,' WORLD POULTRY, June 20, 2007,
http://www.worldpoultry.net /Home/General/2007/6/Tyson-chickens-Raised-Without-
Antibiotics-WPOO 1465W/ [hereinafter WORLD POULTRY].
18. BIOGRAPHY, http://www.louise.house.gov/biography/ (last visited Jan. 6, 2014).
19. Press Release, Slaughter Asks Fast Food Companies, "What's in the Beefr"
(Feb. 16, 2012), available at http://www.louise.house.gov/index.php?option=com
content&task=view&id=2662&temid=100069; see also Letter from Louise M.
Slaughter, Congresswoman, to Fast Food Restaurant Companies (Feb. 16, 2012),
available at http://louise.house.gov/images/user images/gt/stories/Fast Food_
Letter.pdf.
20. "WHAT'S IN THE BEEF?" SURVEY RESULTS, http://www.louise.house
.gov/survey-results (last visited Jan. 6, 2014) [hereinafter Survey Results]; DIRECT
SURVEY RESPONSES, http://www.louise .house.gov/uploads/master_ ist responses
FINAL_final.pdf (last visited Jan. 6, 2014).
21. Survey Results, supra note 20; see also DIRECT SURVEY RESPONSES, supra note
20.
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response rate as well as the ready availability of corporate policies on
antibiotic use speaks to the level of prominence the issue has gained in
corporate consciousness.
IV. REGULATORY RESPONSE TO ANTIBIOTIC RESISTANCE
At the same time that companies and producers have been voluntarily
moving away from reliance on antibiotics in production, efforts to address
this public health issue head on by banning or restricting the use of
antibiotics in agricultural production have moved forward in fits and starts
in the courts and the legislative and administrative branches.
As far back as 1970, the FDA was sufficiently concerned about the
potential risks raised by the use of medically important antibiotics in
livestock production to convene a task force to study the issue.2 2 As the
regulatory body with jurisdiction over approval of all new animal drugs,
the FDA was responsible for having approved the use of antibiotics in food
producing animals, as well as the conditions and restrictions on such use.
In order for it to approve a new drug, the FDA must find that it is safe and
effective; in the case of food-producing animals, this means safe for the
humans that will consume that food, as well as safe for the animals.23 Once
a drug is approved, the FDA may suspend the drug's application if new
evidence (or other information) shows that the drug is not, in fact, safe.24
The FDA's task force concluded that the use of antibiotics, "especially in
growth promotant and subtherapeutic amounts" encourages the
development of bacteria strains resistant to antibiotics.25 The task force set
forth recommendations that included restricting the use of specific
antibiotics in animal feeds for certain uses.26 In response to the task force's
recommendations, the FDA initiated a process with respect to the specified
22. Ctr. for Veterinary Med., U.S. Dep't of Health & Human Servs., supra note 3, at
6.
23. 21 C.F.R. §514.1(b)(8) (2013).
24. 21 U.S.C. §360b(e)(1)(B) (2013). The FDA also establishes safe residue levels
for all animal drugs and withdrawal periods necessary to remain below those maximum
residue levels. See infra note 101. The approved uses of the drug are set forth in its
label, but "extralabel" uses-uses different from what is set forth in the label, such as
variations in doses, frequencies, routes of administration, species, etc.-are also
permitted pursuant to the Animal Medicinal Drug Clarification Act of 1994. 21 U.S.C.
§ 360b(a)(4)(A). However, the FDA may prohibit extralabel use by order if it finds
that the extralabel use could lead to an adverse event affecting the public health. 21
U.S.C. § 360b(a)(4)(D).
25. Antibiotic and Sulfonamide Drugs in Animal Feeds, 37 Fed. Reg. 2444 (Feb. 1,
1972).
26. Id. at 2445.
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antibiotics to withdraw approval unless such drugs were shown to be safe
based on criteria established by the FDA.27 However, the process stalled
for myriad reasons, including the complexities of the scientific and political
issues that surrounded it and was ultimately given up more than twenty-five
28years later.
A similar initiative to ban the extralabel use of cephalosporin, a
critically important and widely used antibiotic for the treatment of disease
in humans, in food producing animals was published in the Federal
Register in 2008, pursuant to the FDA's authority under § 512(e)(1)(B) of
the Food Drug & Cosmetic Act.29 Cephalosporins are commonly used in
food-producing animals, including for controlling E. coli infections that
often lead to early mortality in newly-hatched chicks and turkey poults.30
However, they are also the most frequently prescribed antibiotic for human
diseases, and certain cephalosporins are the preferred drug for treating a
number of serious infections in people, including systemic infections
arising from Salmonella. 31 Nevertheless, the action was withdrawn some
months later in order to allow the FDA the opportunity to consider the
numerous comments it received from various concerned parties on the
matter. 32 In 2012, FDA issued a more narrowly tailored notice regarding
cephalosporin in response to the comments received in 2008." The
modified response would limit certain uses, but continue to allow others.34
The FDA's current policy relies on other strategies it deems more
expedient and, perhaps, less controversial than those reflected in these
earlier initiatives. Currently, the FDA's stated approach is to seek
27. Ctr. for Veterinary Med., U.S. Dep't of Health & Human Servs., supra note 3, at
6; see also Natural Res. Def. Council v. U.S. Food & Drug Admin., 884 F. Supp.2d
127, 136 (S.D.N.Y. 2012); Natural Res. Def. Council v. U.S. Food & Drug Admin.,
872 F. Supp.2d 318, 322-325 (S.D.N.Y. 2012).
28. Ctr. for Veterinary Med., U.S. Dep't of Health & Human Servs., supra note 3, at
6-7; see also Natural Res. Def Council, 884 F. Supp. 2d at 136.
29. New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order
of Prohibition, 73 Fed. Reg. 38,110 (July 3, 2008) (to be codified at 21 C.F.R. pt. 30).
30. Id.
31. Id.
32. New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use;
Revocation of Order of Prohibition; Withdrawal, 73 Fed. Reg. 71,923 (Nov. 21, 2008)
(to be codified at 21 C.F.R. pt. 530).
33. New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order
of Prohibition, 77 Fed. Reg. 735 (Jan. 6, 2012) (to be codified at 21 C.F.R. pt. 530).
34. Id.
35. See generally Antibiotic and Sulfonamide Drugs in Animal Feeds, 37 Fed. Reg.
2444, 2445 (Feb. 1, 1972); see also Natural Res. Def. Council v. U.S. Food & Drug
Admin., 884 F. Supp.2d 127, 134 (S.D.N.Y. 2012); Natural Res. Def. Council v. U.S.
Food & Drug Admin., 872 F. Supp.2d 318, 322-23 (S.D.N.Y. 2012). See generally
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voluntary compliance by all stakeholders in the judicious use of antibiotics
as outlined in its Guidance for Industry #209 and supplemented with
specific recommendations in its Guidance for Industry #213.6 This would
include adoption of two basic principles:
Principle 1: The use of medically important antimicrobial drugs in
food-producing animals should be limited to those uses that are considered
necessary for assuring animal health.
Principle 2: The use of medically important antimicrobial drugs in
food-producing animals should be limited to those uses that include
veterinary oversight or consultation.3 8
With respect to medically important antibiotics currently available on
an over-the-counter basis, FDA's Guidance for Industry #213 calls on
pharmaceutical companies to take action voluntarily in furtherance of the
above principles by revising their labeling to require a prescription from or
oversight by a veterinarian for use in food-producing animals. 39
Frustrated with the time it would take the FDA to review use of
existing antibiotic drugs on a case-by-case basis under the current
regulatory framework, Representative Louise Slaughter sponsored a bill
called the Preservation of Antibiotics for Medical Treatment Act of 2011
(PAMTA).40  If enacted, PAMTA would require approval for the non-
therapeutic use in food-producing animals of any drug used or intended for
FOOD & DRUG ADMIN., U.S. DEP'T OF HEALTH & HUMAN SERVS., FDA's STRATEGY ON
ANTIMICROBIAL RESISTANCE - QUESTIONS AND ANSWERS, http://www.fda.gov/Animal
Veterinary/GuidanceComplianceEnforcement/Guidanceforindustry/ucm216939.htm
(last visited Jan. 6, 2014).
36. Guidance for Industry #209, supra note 3, at 20; See generally Ctr. for
Veterinary Med, U.S. Dep't of Health & Human Servs., Guidance for Industry: New
Animal Drug Combination Products Administered in or on Medicated Feed or
Drinking Water of Food-Producing Animals: Recommendations for Drug Sponsors for
Voluntarily Aligning Product Use Conditions with GFI #209 , 213 GUIDANCE FOR
INDUSTRY 1 (2013), available at http://www.fda.gov/downloads/AnimalVeterinary/
GuidanceComplianceEnforcement/Guidanceforlndustry/UCM299624.pdf [hereinafter
Guidance for Industry #213].
37. Guidance for Industry #209, supra note 3, at 21.
38. Id. at 22. For an analysis of the unique ways these principles would affect the
poultry industry, see David A. Pyle, Judicious Use of Antimicrobials in Poultry
Production, ZOOTECNICA INT'L (July 1, 2006), http://www. zootecnicainternational.
com/article-archive/veterinary/755-judicious-use-of-antimicrobials-in-poultry-
production-.html.
39. Guidance for Industry #213, supra note 36, at 4-5.
40. H.R. 965, 112th Cong. (1st Sess. 2011).
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use in humans to prevent or treat disease or infection caused by
microorganisms within two years of enactment, unless there has been
shown a "reasonable certainty of no harm to human health due to the
development of antimicrobial resistance that is attributable in whole or in
part" to such use.4 ' The bill was referred to the House Subcommittee on
Health on March 14, 2011.42 No further action has been taken. 43
In June 2012, Judge Theodore H. Katz issued the second of two
orders likely to lead to further restrictions on the use of certain medically
important antibiotics in livestock production.4 The first order required the
FDA to follow through on the actions it initiated back in the 1970's with
respect to penicillin and tetracycline-related drugs.45 The second requires it
to reconsider its response to two citizen petitions asking the FDA to ban
certain uses of all antibiotics in the production of food animals. 4 6 The FDA
had argued in both cases that withdrawal hearings would be too time
consuming and resource-intensive and that, instead, it was addressing the
public health concern through the voluntary process set out in its guidance
documents.4 7
Thus, in many ways the voluntary response of food companies to
consumer demands has effected greater and speedier change than the legal
maneuvering has or is likely to do in the near future. However, as will be
discussed below, the current labeling process at FSIS is an impediment to
the effective working of the market.
V. USE OF ANTIBIOTICS IN COMMERCIAL POULTRY PRODUCTION
In May 2007, FSIS approved Tyson's proposed use of the label
"raised without antibiotics" on chicken products, 4 8 and Tyson launched a
$70 million advertising and marketing campaign related to its new product
4 1. Id.
42. LIBRARY OF CONGRESS, BILL SUMMARY & STATUS, 1 12 T CONGRESS (2011 -
2012), H.R. 965, ALL INFORMATION, http://thomas.loc.gov/cgi-bin/bdquery/z?dl 12:
HR00965:@@@L&summ2=m& (last visited Jan. 7, 2014).
43. LIBRARY OF CONGRESS, BILL SUMMARY & STATUS, 112TH CONGRESS (2011 -
2012), H.R. 965, ALL CONGRESSIONAL ACTION, http://thomas.loc.gov/cgi-bin/bdquery/
z?dl 12:HR00965:@@@X (last visited Jan. 7, 2014).
44. See generally Natural Res. Def. Council v. U.S. Food & Drug Admin., 884 F.
Supp.2d 127 (S.D.N.Y. 2012); see also Natural Res. Def. Council v. U.S. Food & Drug
Admin., 872 F. Supp.2d 318, 318 (S.D.N.Y. 2012).
45. Natural Res. Def Council, 884 F. Supp.2d at 151.
46. Natural Res. Def Council, 872 F. Supp.2d at 341-42.
47. Natural Res. Def Council, 884 F. Supp.2d at 140; Natural Res. Def Council,
872 F. Supp.2d at 325.
48. WORLD POULTRY, supra note 17.
2312013]
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line.4 9 Tyson had determined that a large proportion of its customer base-
over ninety percent-may be willing to purchase chicken raised without
antibiotics and were willing to pay a premium to do so.5 o Tyson's then-
Senior Vice President of Fresh Meal Solutions, Dave Hogberg, was quoted
as saying, "[w]e are the first major poultry company to offer fresh chicken




Intensive animal agriculture began in the early twentieth century,
when the production of crops such as corn and soybeans outstripped the
food demands of population growth and could be redirected to feed for
animal production. 5 2 "Vertically integrated" poultry production is now the
norm, meaning that one company controls all aspects of production from
when the eggs are laid to when the packaged meat product is stocked at the
grocery. 3 While large-scale production has enabled greater quantities of a
more cost-effective, consistent-quality product to be produced, it also
increases the risks associated with disease in flocks. More animals raised
49. Tyson and USDA Reach an Agreement on Antibiotics Label, WORLD POULTRY,
Dec. 21, 2007, http:// www.worldpoultry.net/Home/General/2007/12/Tyson-and-
USDA-reach-an-agreement-on-antibiotics-label-WP002026W/.
50. WORLD POULTRY, supra note 17.
5 1. Id.
52. PEW COMMISSION, supra note 13, at 5. Traditionally, in the United States,
individuals and families raised small crops of grains, fruits, and vegetables and small
numbers of farm animals in order to produce the food needed to support themselves.
Id. at 1. This "subsistence farming" continued on a widespread basis until well into the
1800's when the development of mechanical agricultural tools made more intensive
production possible. Id. The production of crops on an industrial scale, supported by
advances in transportation, food preservation, genetic selection, chemical fertilizers and
pesticides, etc., fueled the growing urbanization of the country. Id. at 1, 3. Food could
now be produced in the countryside and transported to cities. Id.
53. Id. at 5. The poultry company typically contracts with independent growers to
raise the chicks or turkey poults until they are ready to be slaughtered and processed,
but supplies and controls what they are fed, whether and how they are medicated, and
other aspects of their care. Id. See also AM. ACAD. OF MICROBIOLOGY, THE ROLE OF
ANTIBIOTICS IN AGRICULTURE (2002), available at http://www.fws.gov/fisheries
/aadap/PDF/the%20role%20of/o2Oantibiotics%20in%20agriculture%202002%2OAmer
%20Acad%2OMicrobiologistspdf.pdf. This vertical integration grew out of the process
employed in meeting contracts with the War Department during World War II for
poultry products for the troops and has continued as the preferred model for large scale
animal production. PEW COMMISSION, supra note 13, at 5; see also H. STEINFELD ET
AL., LIVESTOCK'S LONG SHADOW: ENVIRONMENTAL ISSUES AND OPTIONS (2006),
available at ftp://ftp.fao.org/docrep /fao/010/a070Ie/a0701e.pdf. Vertical integration
allows the producer to take advantage of economies of scale and exercise greater
control over all the factors affecting the quality and safety of the product. PEW
COMMISSION, supra note 13, at 5; see also STEINFELD ET AL., supra.
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in close quarters means greater possibility of disease outbreaks, the ability
for disease to spread more quickly and for the producer to experience
greater losses if it does. 5 As a result, availability of antibiotics has been
essential to the success of large-scale animal production.
Antibiotics are used to treat disease outbreaks in livestock as they are
in humans. In poultry production, though, rather than treating individual
sick birds, medicine is administered in food or water to the entire flock.56
The reasons for this are two-fold: a) due to the large numbers of birds
comprising a flock, it is impractical to identify, separate, and treat each
individual chicken or turkey experiencing symptoms;5 7 and b) because of
the close quarters and densely populated houses, the remainder of the flock
is at great risk of contracting or having already contracted the illness by the
time an outbreak is identified. Accordingly, treatment of the whole flock
serves both a therapeutic and prophylactic role.
In addition, in the 1940's, researchers trying to understand the
makeup of animal proteins accidentally discovered that poultry fed
antibiotics grew faster than others. 59 As a result, producers began routinely
54. David Tilman et al., Agricultural Sustainability and Intensive Production
Practices, 418 NATURE 671, 671 (2002), available at http://www.nature.com
/nature/journal/v418/n6898/pdf/nature0 014.pdf.
55. Phillips et al., supra note 3, at 28.
56. Id. at 29 (stating that "[w]hen antibiotic treatment is necessary, it often has to be
administered to food animals in feed or water. Individual animal treatment is almost
never practical for poultry").
57. Id.; see also AM. ACAD. OF MICROBIOLOGY, supra note 53, at 3 (noting that
"[p]oultry generally are given antibiotics in feed or water since individual treatment is
impractical and not economical; this method of dispensing antibiotics exposes all the
animals to antibiotics, but the individual dose is unknown and inconsistent").
58. Phillips et al., supra note 3, at 29 (stating that "[i]n livestock production, the
objective is to limit progression of disease in the population, since illness decreases
animal performance. Herd or flock treatment is often indicated when illness is first
recognized in a small proportion of the animals").
59. F.T. Jones & S.C. Ricke, Observations on the History of the Development of
Antimicrobials and Their Use in Poultry Feeds, 82 POULTRY Sci. 613, 613 (2003),
available at http://ps.fass.org/content/82/4/613.full.pdf+html; Phillips et al., supra note
3, at 29. Phillips et al. note that:
[t]he growth promoting effects of antibiotics were first discovered in
the 1940s when chickens fed by-products of tetracycline
fermentation were found to grow faster than those that were not fed
those by-products. Since then, many antimicrobials have been
found to improve average daily weight gain and feed efficiency in
livestock in a variety of applications, and this is known as 'growth
promotion'.
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adding antibiotics to feed to promote growth.o Veterinarians now
understand that the antibiotics work to prevent or control coccidiosis and
other diseases of the intestinal tract which interfere with effective feed
conversion. 6 1 Thus, even though still referred to as "growth promotants,"
they are doing so by preventing or controlling disease.6 2
VI. CONFUSING, INACCURATE, AND MISLEADING LABELING
After Tyson's new products had already gone to market, FSIS
withdrew its consent for the label after realizing that Tyson used
ionophores in its feed to prevent coccidiosis. 6 3 Ionophores are a class of
antibiotics used, not for treating bacterial infections but, rather, to treat
parasites in the intestinal tract.64 Though not used in human medicine and
not deemed antibiotics by the FDA, ionophores were considered antibiotics
by FSIS. 65 After negotiations, FSIS and Tyson agreed on a new, revised
60. The goal of large-scale, intensive animal production is to produce the greatest
number of pounds of safe, high-quality product for the lowest cost. See generally, Jay
P. Graham et al., Growth Promoting Antibiotics in Food Animal Production: An
Economic Analysis, 122 PUB. HEALTH REP. 79 (2007), available at http://www.
jhsph.edu/sebin/s/a/ antibioticspoultry07.pdf. To measure success in this effort, the
poultry industry uses the feed conversion ratio. Id; see also PEW COMMISSION, supra
note 13, at 5. Factors that affect the cost of feed, the amount of feed consumed, or the
amount of weight gained will all affect the feed conversion ratio. In addition, disease
also affects the cost of production, as money spent on raising the chicks or turkey
poults prior to the death of the animal will not contribute to marketable product,
additional expense will be incurred in dealing with the consequences of the outbreak
(including treatment of animals and disposition of carcasses). Further, even if diseased
birds do not die, they may, nevertheless, be excluded from sale due to safety or quality
issues-known in the industry as "condemnations." Something that increases weight
gain without requiring additional feed (after taking into account the cost of the growth-
promoting additive) will improve the feed conversion ratio. See Graham et al., supra,
at 83.
61. Video: Poultry Insight: Why and When are Antibiotics Used in Poultry
Production?, WORLD POULTRY, Nov. 13, 2012, http://www.worldpoultry.net/
Home/General/2012/1 1/Poultry-Insight-Why-and-when-are-antibiotics-used-in-
poultry-production- 1104566W/ [hereinafter Poultry Insight].
62. Id.
63. USDA Wants Removal of Tyson's "No Antibiotics Label", WORLD POULTRY,
Nov. 20, 2007, http://www.worldpoultry.net/Broilers/Markets-Trade/2007/1 1 /USDA-
wants-removal-of-Tysons-ano-antibiotics-labela-WPOO1924W/ [hereinafter WORLD
POULTRY 11].
64. Poultry Insight, supra note 61.
65. WORLD POULTRY II, supra note 63.
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label - "raised without antibiotics that impact antibiotic resistance in
humans."66
In January, however, Tyson was sued by several of its major
competitors, claiming that the labeling was inaccurate and misleading,
initially because the label implies that the other producers are using those
types of drugs, which is not the case, and later because Tyson, in fact,
injected the eggs with the antibiotics gentamicin and ceftiofur, in
conjunction with certain vaccinations made prior to hatch. The suit by
68competitors was followed by a class action lawsuit by consumers and a
withdrawal of approval of the label by the FSIS, in light of the new
information about in ovo injections of antibiotics that are approved for use
with humans.69
Ultimately, Tyson stopped using the labeling and brought suit against
the USDA, saying that the regulatory process was flawed.70
66. Tyson and USDA Reach an Agreement on Antibiotics Label, supra note 49;
Tyson to Use New Label for 'Raised Without Antibiotics Chicken', WORLD POULTRY,
Jan. 2, 2008, http://www.worldpoultry.net/Broilers/Markets-Trade/2008/l/Tyson-to-
use-new-label-for-Raised-Without-Antibiotics-Chicken-WP002036W/.
67. Sanderson Farms, Inc. v. Tyson Foods, 547 F. Supp. 2d 491 (D. Md. Apr. 22,
2008); Tyson Appeal Denied in 'Raised Without Antibiotics' Case, WORLD POULTRY,
May 2, 2009, http://www.worldpoultry.net/Home/General/2008/5/Tyson-appeal-denied
-in-raised-without-antibiotics-case-WP002485W/; U.S. Court Says Tyson Must Stop
Advertising Claims, WORLD POULTRY, Apr. 24, 2008, http://www.worldpoultry.net
/Broilers/Markets-Trade/2008/4/US-court-says-Tyson-must-stop-advertising-claims-
WP002460W/; U.S. Poultry Giants Fight Over Antibiotic Use, WORLD POULTRY, Apr.
11, 2008, http://www.worldpoultry.net/Broilers/Markets-Trade/2008/4/US-poultry-
giants-fight-over-antibiotic-use-WP0024 11 W/; see also Second Amended Complaint,
Sanderson Farms, Inc. v. Tyson Foods, No. 1:08-cv-00210, 2008 WL 4334901 (D. Md.
May 5, 2008) (noting that "[g]entimicin is an antibiotic approved for use in human
medicine" and "[c]eftiofur is a third generation cephalosporin; cephalosporins are
approved for use in human medicine").
68. Rory Harrington, Tyson Agrees to Pay $5m in "Antibiotic-free" Chicken
Settlement, FOODPRODUCTIONDAILY.COM, Jan. 15, 2010, http://www.foodproduction
daily.com/Processing/Tyson-agrees-to-pay-5m-in-antibiotic-free-chicken-settlement;
Tyson Removes 'Raised Without Antibiotics' Label, WORLD POULTRY, June 4, 2008,
http://www.worldpoultry.net /Broilers/Markets-Trade/2008/6/Tyson-removes-raised-
without-antibiotics-label-WP002596W/; Tyson Settles Suit Over Antibiotic Labeling,
WORLD POULTRY, Jan. 22, 2010, http://www.worldpoultry.net/Home/General
/2010/1/Tyson-settles-suit-over-antibiotic-labelling-WP006982W/.
69. Am. Veterinary Med. Ass'n, USDA Rescinds "Raised Without Antibiotics"
Label on Tyson Chicken, July 15, 2008, https://www.avma.org/News/JAV
MANews/Pages/080715s.aspx.
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FSIS is responsible for approving the types of claims a company may
make on its labeling regarding use of antibiotics.71 Unlike food labels
regulated by the FDA, the content of all meat and poultry food labels must
be approved by FSIS in advance.72 Certain information is mandatory, such
as product name, country of origin, list of ingredients, and certain nutrition
information, but other information may be included at the discretion of the
producer, if it is truthful and not misleading. 73
A particular category of discretionary information is known as
"animal raising claims" or "production claims" and has to do with how the
animal that produced the food product was raised.74  Examples include
"vegetarian fed diet," "free-range," or "not fed animal by-products."75
Within this category are claims about whether or under what circumstances
the animal was treated with antibiotics.76
Currently, while any such claim must be approved by FSIS, there is
not a defined set of acceptable claims or claim language dictated by FSIS
or established guidelines for how an animal must be raised to satisfy the
requirement that the claim is truthful and not misleading.7 7
The Agricultural Marketing Service (AMS) of the USDA plays a
different but related role in the labeling of meat products, by offering
voluntary "Process Verified" programs. 7 8  These programs enable
companies to have their facilities audited to verify specific production or
animal raising claims.79 Once verified, they may include a "USDA Process
71. Poultry Products Inspection Act, 21 U.S.C. §§ 451-72 (2012).
72. Id.; OFFICE OF POLICY, PROGRAM, & EMP. DEv., U.S. DEP'T OF AGRic., A GUIDE
To FEDERAL FOOD LABELING REQUIREMENTS FOR MEAT, POULTRY, AND EGG
PRODUCTS 4 (2007), available at http://www.fsis.usda.gov/PDF/Labeling
RequirementsGuide.pdf [hereinafter GUIDE]; See generally 9 C.F.R. §§ 300-592.
73. See Am. Veterinary Med. Ass'n, supra note 69.
74. OFFICE OF POLICY, PROGRAM, & EMP. DEV., U.S. DEP'T OF AGRIC., ANIMAL
PRODUCTION CLAIMS OUTLINE OF CURRENT PROCESS 1, available at
http://www.fsis.usda.gov/OPPDE/larc/Claims/RaisingClaims.pdf.
75. FOOD SAFETY & INSPECTION SERV., U.S. DEP'T OF AGRIC., ANIMAL RAISING
CLAIMS IN THE LABELING OF MEAT AND POULTRY PRODUCTS, POWERPOINT
PRESENTATION FROM PUBLIC MEETING REGARDING ANIMAL RAISING CLAIMS SLIDE 4
(2008), available at http://www.fsis.usda.gov/PDF/ClaimsPoretta 101408.pdf.
76. GUIDE, supra note 72, at 18, 21.
77. Id. at 18-21; see also FOOD SAFETY & INSPECTION SERV., U.S. DEP'T OF AGRIC.,
supra note 75, at slides 6-8.
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Verified" seal on their labels along with the approved claim."o As with
animal raising claims in general, most claims that have been verified
through this program were put forth by the company and include "All
Vegetarian Diet," "No Animal By-Products," "Humanely Raised,"8'
"Raised Cage Free," and "No Antibiotics Ever," among others.82 However,
the AMS also develops programs with which companies and producers
may choose to comply, with the expectation that it will bring added value
to their products.83 One such program that touches on antibiotics usage is
called "Never Ever 3": no antibiotics, no growth promotants, and no animal
by-products-"never ever".8 4 This program was launched in April 2009,
but does not appear to have gotten much traction; as of the October 4,
2012, update, no poultry products are listed on the Official Listing of
80. AGRIC. MKTG. SERV., U.S. DEP'T OF AGRIC., QUALITY SYSTEMS VERIFICATION
PROGRAMS GENERAL POLICIES AND PROCEDURES 1 (2010), available at
http://www.ams.usda.gov/AMSvl.0/getfile?dDocName=stelprdc5O73953 [hereinafter
Quality Systems]; AGRIC. MKTG. SERV., U.S. DEP'T OF AGRIC, USDA PROCESS
VERIFIED PROGRAM 9 (2011), available at http://www.ams.usda.gov/AMSvl.O
/getfile?dDocName=stelprdc5097560 [hereinafter Verified Program].
81. AGRIC. MKTG. SERV., U.S. DEP'T OF AGRIC., OFFICIAL LISTING OF APPROVED
USDA PROCESS VERIFIED PROGRAMS 9 (2013), http://www.ams.usda.gov/AMS
v1.0/getfile?dDocName= STELPRDC5081908 [hereinafter Approved Programs],
noting that the Humanely Raised Program claim is in accordance with Perdue's Best
Practices, which include:
* Education, training, and planning
* Hatchery Operations
* Proper Nutrition and Feeding
* Appropriate Comfort and Shelter
* Health Care
* Normal Patterns of Behavior
* On-Farm Best Practices
* Catching and Transportation
* Processing
Humanely Raised Program claim is based on the principles outlined in the National
Chicken Council's Animal Welfare Guidelines to ensure the proper care, management,
and handling of broiler chickens. See generally NAT'L CHICKEN COUNCIL, ANIMAL
WELFARE GUIDELINES AND AUDIT CHECKLIST FOR BROILERS, available at http://www.
nationalchickencouncil.org/wp-content/uploads/2012/01/NCC-Animal-Welfare-
Guidelines-20 10-Revision-BROILERS.pdf.
82. Approved Programs, supra note 8 1, at 1.
83. AGRIC. MKTG. SERV., U.S. DEP'T OF AGRIC., ANIMAL RAISING CLAIMS 25-27
(2008), available at http://www.fsis.usda.gov/PDF/AnimalRaisingClaims_101408
.pdf [hereinafter Transcript].
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Approved USDA Process Verified Programs as complying with this
program.
Tyson's foray into the market for no antibiotic products is illustrative
of the dilemmas posed by the current labeling system. But it is not an
isolated incident. In conjunction with Consumer Reports' survey of
consumers noted above, the organization also researched the availability of
meat that was labeled in a manner indicating that antibiotics had not been
used in its production.8 6 Their researchers identified a plethora of labels in
the marketplace, not all of which had been approved by the USDA and
many of which had the potential to be confusing if not actually
misleading. 87
In response to the Tyson fiasco, USDA began a process of reviewing
its policies with respect to animal raising claims in meat and poultry
product labels.88 The agency published a notice to solicit public input and
held a public meeting.89
VII. TRUTHFUL AND NON-MISLEADING LABELING ABOUT
ANTIBIOTICS IS NEEDED
Participants in the meeting represented stakeholders ranging from
farmers to the Union of Concerned Scientists, poultry production
companies to consumer protection interest groups.90 Surprisingly, given
the diverse backgrounds of the group, the comments were consistent in
calling on the USDA to promulgate clear and coherent standards for animal
raising claims, rather than approving such claims on a case-by-case basis,
and for making the standards and the process more transparent. 91
Comments also highlighted the need for compliance with standards to be
verified by either the AMS process verified program or certified third party
85. See generally Approved Programs, supra note 81.
86. CONSUMER REPORTS, supra note 16, at 3.
87. Id. at 3-4; see also Joanne Chen, Meaty Confusion, Clarified, HEALTH, Apr.
2006, at 161, available at http://www.keepantibioticsworking.com/new/KAW
files/64_2_80789.pdf, Gosia Wozniacka, Food Labels Confuse Consumers As 'Eco-
Label' Options Multiply, HUFFINGTON POST, Nov. 11, 2012, http://www.huffington
post.fr/2012/1 1/12/food-labels-confusing n_211 6609.html.
88. Am. Veterinary Med. Ass'n, supra note 69.
89. Product Labeling: Use of the Animal Raising Claims in the Labeling of Meat
and Poultry Products, 73 Fed. Reg. 60,228 (Oct. 10, 2008); FOOD SAFETY &
INSPECTION SERV., U.S. DEP'T OF AGRIC., supra note 75, at slides 24-30; Transcript,
supra note 83, at 16-17.
90. See generally Transcript, supra note 83.
91. See generally id.
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auditors.92 Participants in the meeting were clear that both producers and
consumers suffer when false or confusing claims are put forth in the
marketplace.9 3
We have seen that consumer demand affects supply in the context of
antibiotic use. When a purchaser, such as McDonalds or Bon Appetit,
adopts a policy precluding or restricting antibiotics usage, then their
suppliers will follow suit.94 Large purchasers have the leverage to
negotiate requirements in supply contracts not only regarding how product
is produced, but also rights to audit production facilities or take other steps
to ensure compliance. Consumers, however, do not have these options.
They are handicapped by a lack of adequate, trustworthy information to
make the purchasing decision before them. The issue is complex, as
consumers do not understand the potential risks and the tradeoffs,
companies control information about production methods, and there is no
way for consumers to verify claims being made.
The Tyson case highlights these dilemmas: Are ionophores antibiotics
or not and why are they used? What is meant by "raised" without
antibiotics"? Do other poultry companies use antibiotics? Which
antibiotics impact antibiotic resistance in humans? Are there other risks
associated with using antibiotics? Without an understanding of the
scientific issues raised by these questions or the information about the
production practices of the various producers offering products in the
marketplace, consumers are unable to evaluate the superiority of a product.
They cannot determine whether additional value is present (e.g., whether
the differentiating factor really does make the product safer) or trust that
the product is what it purports to be (i.e., that the company is telling the
truth about its unique production practices). As a result of this
"asymmetrical information," the consumer will not be willing to pay a
premium for specially labeled products. 95  In turn, if consumers are
92. Id.
93. Id.
94. Weise, supra note 14.
95. See generally George A. Akerlof, The Market for "Lemons": Quality
Uncertainty and the Market Mechanism, 84 Q. J. ECON. 488 (1970). George A.
Akerlof was awarded the Nobel Prize in Economics in 2001 jointly with A. Michael
Spence and Joseph E. Stiglitz "for their analyses of markets with asymmetric
information." See THE SVERIGES RIKSBANK PRIZE IN ECONOMIC SCIENCES IN MEMORY
OF ALFRED NOBEL 2001, http://www.nobelprize.org/nobelprizes/economics
/laureates/2001/ (last visited Jan. 10, 2014). Akerlof's work was set forth in this article
exploring the effect of asymmetrical information on markets in the context of the
market for used cars. See generally Akerlof, supra. He noted that though some used
cars were high quality and other used cars were "lemons," only sellers had access to the
information needed to evaluate the quality of a given used car. Id at 489. As a result,
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unwilling to buy any "no antibiotic" products because their trust has been
compromised, then companies will not choose to incur added expense to
change production methods.96
The USDA has developed new guidance on such labeling, currently
in the process of being cleared for release to the public, which will
establish the minimum requirements for a "no antibiotics" label.
However, it will allow producers to make such a claim on a time limited
basis, such as "within X days of finish." 98 Claims will not be required to be
verified by third party certification.99
It remains to be seen what the new guidance will actually be.
However, what has been suggested does not look promising. While it
would establish a minimum standard for a "no antibiotics claim," it would
not ensure such claims were verified, and would allow for the possibility of
different versions of similar claims, some of which may not be meaningful
in terms of having an appreciable difference in combating the spread of
antibiotic resistance (for example, as to the number of days prior to finish
that antibiotic usage is withdrawn). Likewise, no allowance seems to have
been made for appropriate and beneficial uses of antibiotics supporting
food safety or animal welfare, such as the use of antibiotics to treat
diagnosed disease outbreaks under the supervision of a veterinarian.
It appears that FSIS will be proposing clear requirements for what "no
antibiotics" means and that standard will likely specify that there be no in
ovo injections of antibiotics and no usage of ionophores in raising
poultry.100 If this standard is adopted, it will be a step forward from the
current state of the law. It will most likely be used by smaller operations
that are set up to employ the husbandry and management practices
conducive to protecting animal welfare and food safety at a premium price
because buyers could not tell a "lemon" from a high-quality used car, they would be
unwilling to pay a price representative of the value of the quality cars for fear that they
might, in fact, be over-paying for a lemon. Id. As a result, sellers of good cars would
be unlikely to sell in a market where they could not command a fair price and,
eventually, the market would be made up entirely of lemons. Id. at 490. Akerlof saw
government regulation mandating disclosure as one possible method for allowing
buyers and sellers to reach the equilibrium of information necessary to allow the
market to function properly. Id. at 488.
96. See generally Akerlof, supra note 95.
97. Letter from Thomas J. Vilsack, Secretary, U.S. Dep't of Agric., to Urvashi
Rangan, Director of Consumer Safety and Sustainability, Consumer Reports (July 6,
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as well as larger producers who can dedicate a portion of their operations to
these practices. For larger producers, if antibiotic treatment becomes
necessary to respond appropriately to disease outbreaks, they have the
option to re-direct treated flocks to conventional markets.
Nevertheless, verification is essential. As FSIS's experience with
Tyson illustrates, relying on company-provided information to establish the
appropriateness of a claim is insufficient. Whether this inability is as a
result of intentional misrepresentation by an applicant or more benign
causes, FSIS will not always be able to determine whether a claim is, in
fact, truthful and not misleading. There may be confusion arising from a
lack of standardized terms, or from a failure by FSIS to ask for additional
information or clarification regarding an applicant's practices or
procedures. In any case, onsite verification is needed to overcome this
problem. Currently, FSIS does not have the authority to compel companies
to obtain third-party verification nor the jurisdiction to conduct such
verification procedures directly. Accordingly, legislative action would be
required to enact this requirement. However, obtaining approval from
Congress for such regulatory authority may well be easier than obtaining
the approval of more sweeping legislation dealing with antibiotic
resistance, such as PAMTA. PAMTA would immediately restrict the
production practices of the majority of meat and poultry producers,
potentially having an adverse impact on the cost of consumer products with
a corresponding effect on sales, production levels, jobs, and grower
contracts, as well as, ultimately, company profits and share prices. By
contrast, authorizing FSIS to require verification of animal raising claims
would involve merely an additional regulatory burden on companies
choosing to adopt a voluntary marketing label on their products. This
should make it more palatable to members of Congress and, therefore,
more likely to be enacted. In addition, a similar program has already been
successfully put into practice in the National Organic Program, allowing
companies to use either third party certification or the AMS "Process
Verified" program.or
In addition, the diversity of language that is likely to arise as a result
of FSIS evaluating and approving claims on a case-by-case basis, means
that the confusion associated with labeling will remain, as well as the
potential for misleading claims and misinformation. As with Tyson,
labeling that indicates a distinction that is not scientifically meaningful or
101. 7 C.F.R. § 205; AGRIC. MKTG. SERV., U.S. DEP'T OF AGRIC., NATIONAL
ORGANIC PROGRAM, http://www.ams.usda.gov/AMSvl.O/ams.fetchTemplateData.
do?template=TemplateA&navlD=NationalOrganicProgram&leftNav=NationalOrganic
Program&page=NOPNationalOrganicProgramHome&acct=AMSPW (last visited Jan.
10,2014).
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advertises a practice that does not differ materially from that of the industry
in general are or have the potential to be misleading. By way of example,
is there scientific evidence that treating food producing animals with
antibiotics for a portion of their lives but then removing them from the
drugs for a specified period before processing would make an appreciable
difference in the levels of antibiotic-resistant microorganisms such animals
carried? By law, food producing animals are already required to be
removed from antibiotics for a mandated withdrawal period sufficient to
ensure no antibiotic drug residue remains in their tissues, so a label
highlighting such a practice must not imply that the purpose of such
extended time period is related to residues, or suggest that this practice is
superior to that of competitors in removing residues. 10 2  If there is no
evidence that fewer antibiotic-resistant microorganisms are present in such
animals than in others which are merely removed from antibiotics for the
mandatory withdrawal period, then the claim would be misleading in
implying superiority in this respect as well.
In the Tyson case, the court found, based on consumer survey data
provided by the plaintiff, that "[p]laintiffs have demonstrated that
consumers are in fact misled by [Tyson's] advertisements," even the
qualified version stating "raised without antibiotics that impact antibiotic
resistance in humans.", 0 3 Given the difficulty with this language, other
102. The FDA is responsible for establishing tolerances for animal drugs under the
Federal Food, Drug, and Cosmetic Act. Under the authority of the Poultry Products
Inspection Act, as well as the Federal Meat Inspection Act and the Egg Products
Inspection Act, and as spelled out in the National Residue Program, FSIS monitors
chemical residues in poultry, meat, and egg products to ensure they fall within the
FDA-established tolerances. See generally FOOD SAFETY & INSPECTION SERV., U.S.
DEP'T OF AGRIC., NATIONAL RESIDUE PROGRAM 2010 SCHEDULED SAMPLING PLANS
(2011), available at http://www.fsis.usda.gov/PDF/2010 blue book.pdf; OFFICE OF
PUB. HEALTH SC., U.S. DEP'T OF AGRIC., 2008 FSIS NATIONAL RESIDUE PROGRAM
DATA (2009), available at http://www.fsis.usda.gov/PDF/2008 RedBook.pdf.
103. Sanderson Farms, Inc. v. Tyson Foods, 547 F. Supp. 2d 491, 503 (D. Md. Apr.
22, 2008). Plaintiffs expert, Professor Mazis, conducted a consumer survey regarding
the advertising language (which mirrored the labeling) used by Tyson in its new
product line. Id. at 498-99. Based on the survey results, he reached the following
conclusions:
First, the individuals that participated in the survey largely
responded the same way to the qualified "Raised Without
Antibiotics that impact antibiotic resistance in humans" claim as
they did to the unqualified "Raised Without Antibiotics" claim.
Second, participants viewed both the unqualified and qualified
claims as implying that Tyson's chicken is safer and healthier than
competitors' chicken. Id. at 499.
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qualifications or nuanced distinctions are likely to be similarly confusing, if
not misleading. Terms like subtherapeutic, therapeutic, growth promotion,
prevention, prophylaxis, or control do not have standard definitions and
there is disagreement even within the industry and scientific community as
to how to define and monitor the use and purpose of antibiotics. For
example, in the poultry industry, would it be possible to assert that
antibiotics are used solely for therapeutic uses given the practice of treating
an entire flock when an outbreak is detected in some birds? Some birds
within a flock may be treated for disease while the rest of the flock is
considered at risk and treated as well. Would such use necessarily be both
therapeutic and preventative? How would such a determination be made?
Without an in depth understanding of husbandry practices, the consumer
would not be able to appreciate the issues surrounding such use. Therefore,
any use of these terms in labeling should not be permitted.
Clearly, evaluating differing claims regarding antibiotics requires a
knowledge and understanding of complex scientific issues with respect to
which the scientific community is, as yet, unable to agree. Accordingly,
case-by-case approval of claims should give way to a limited set of
acceptable claims, designed to convey information and allow consumers to
choose between reasonable alternatives.
One of those alternatives should take into account the issue of animal
welfare and allow consumers to support the continued move to more
responsible uses of antibiotics in the industry that is beginning to take
place, with the assurance that animal welfare and food safety issues will not
be compromised during the transition. Certainly, the industry is
implementing improvements to husbandry and management practices that
make routine use of antibiotics for disease prevention less necessary.
However, in the context of large-scale animal production, it is not possible
to completely eliminate disease outbreaks and alternative therapies are not
widely available, if at all.' 05 If companies were unable to market products
In addition, the court noted that, based on a series of open-ended questions asked to
consumers about the advertising, covering both the original "Raised Without
Antibiotics" claim and the later, qualified, "Raised Without Antibiotics That Impact
Antibiotic Resistance in Humans" claim, "consumers process [both] messages in the
same fashion. In short, consumers believe that there are no antibiotics given to Tyson's
chickens." Id. at 499-500.
104. Video: Poultry Insight: What Would Happen if We Stop Using Antibiotics All
Together in the Poultry Industry?, WORLD POULTRY, Nov. 13, 2012, http://www.world
poultry.net/Home/General/2012/l 1/Poultry-Insight-Why-and-when-are-antibiotics-
used-in-poultry-production-1 104566W/ [hereinafter Poultry Insight II].
105. Id.; see also Michael J. Crumb, Organic Livestock: Few U.S. Vets Trained To
Treat Organic Livestock, SALON, Jan. 4, 2012, http://www.salon.com/2012/01/04
/few us vets trained to treat organic livestock_2/.
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from animals treated with antibiotics, the concern is that treatment would
be withheld or delayed, with animal suffering or poorer food safety
compliance being the result. 10 6 Judicious use of antibiotics for treatment,
under the supervision of a veterinarian, represents a step in the right
direction for purposes of combating antibiotic resistance, and companies
complying with this standard should be able to inform consumers of their
policies and practices. In addition, adopting this standard as an acceptable
raising claim would not only help along the changes already underway in
the market but would align with the process unfolding more slowing at
FDA. By permitting companies to label their products "judicious use of
antibiotics only," or words to that effect, companies should be able to
market a product at a somewhat higher price than products unable to make
this claim. This would incentivize them to adopt and comply with the
voluntary principles set forth in FDA's Guidance for Industry #209, as the
additional market price would compensate for the added costs associated
with the more labor intensive husbandry and management practices
required to comply with these principles.' 07
Consumers, in turn, would have the option of purchasing
conventionally raised products at the lowest available price, products
"raised without antibiotics," presumably offered at the highest price (other
than organic products, which impose a variety of requirements on the
raising of the animal in addition to prohibiting use of antibiotics at any time
in the lifecycle), or products complying with the FDA's voluntary
principles for the judicious use of antibiotics, which would presumably be
offered at a price somewhere in between.
In addition to allowing for the free flow of information that should
positively impact buying and selling decisions in the market, this robust,
mandatory labeling scheme can also serve a consumer education role. By
aligning FSIS and AMS labeling guidelines regarding antibiotics with the
FDA's current thinking on judicious antibiotic usage, the agencies can
present a unified message regarding the issue and better inform the public
106. See generally Letter from Members of the Coalition for Animal Health to Nancy
Pelosi & Steny Hoyer, U.S. House of Rep. (July 20, 2009), available at http://www.
meatami.com/ht/a/GetDocumentAction/i/51781; JOINT AVMA-FEDERATION OF
VETERINARIANS OF EUROPE STATEMENT ON RESPONSIBLE AND JUDICIOUS USE OF
ANTIMICROBIALS, https://www.avma.org /KB/Policies/Pages/Joint-AVMA-Federation-
of-Veterinarians-of-Europe-Statement-on-Responsible-and-Judicious-Use-of-
Antimicrobials.aspx (last visited Jan. 11, 2013); Video: Poultry Insight: Why and When
are Antibiotics Used in Poultry Production?, WORLD POULTRY, Nov. 13, 2012,
http://www.worldpoultry.net/Home/General /2012/1 1/Poultry-Insight-Why-and-when-
are-antibiotics-used-in-poultry-production- 104566W/.
107. Ctr. for Veterinary Med., U.S. Dep't of Health & Human Servs., supra note 3, at
20.
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of the different roles each agency plays in addressing the public health
issues related to it.
VIII. CONCLUSION
This article has provided a brief overview of the myriad and complex
issues related to the role the agricultural industry and, specifically, poultry
companies and producers, play in the development of antibiotic resistant
bacteria. As with any complex problem, there is no one solution-no
magic pill-that will effect a cure. The FDA must protect the efficacy of
antibiotics and other antimicrobial drugs on a case-by-case basis through its
jurisdiction over new animal drugs. As new evidence emerges, the
withdrawal of drugs or restriction of their use may be appropriate as well,
but the process to do so is necessarily time consuming and demanding on
the resources of the agency. As such, realistically, these changes can be
instituted only at a slow pace.
Even while we wait for FDA to take action, industry may be spurred
to action by the demands and preferences of the consumer, provided they
are able to recoup the added cost of transition and innovation and
consumers have the confidence needed in the improved product to pay
more for it. If these incentives are reinforced by appropriate regulation
enforced by FSIS, then before the FDA is able to reconsider all of the
existing animal drug approvals, the industry's reliance on antibiotics in
poultry production may have flown the coop.
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